Period of time： 2014年7期
Publisher： Informa Healthcare
Founded in： 2005
Total resources： 64
ISSN： 1742-5255
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 7
Menu
Access to resources
Recommend
Microdosing and drug development: past, present and future
Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 7 , Vol. 9, Iss. 7, 2013-07 , pp.Metabolic and toxicological considerations of newly approved prostate cancer drugs
By Tsao Che-Kai,Liaw Bobby,Yee Tiffany,Galsky Matthew D,Oh William K in (2013)
Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 7 , Vol. 9, Iss. 7, 2013-07 , pp.Anti-Parkinson's disease drugs and pharmacogenetic considerations
Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 7 , Vol. 9, Iss. 7, 2013-07 , pp.Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases
By Lima Breno R,Nussenblatt Robert B,Sen H Nida in (2013)
Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 7 , Vol. 9, Iss. 7, 2013-07 , pp.Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies
By Gibney Geoffrey T in (2013)
Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 7 , Vol. 9, Iss. 7, 2013-07 , pp.By Donadini Marco P,Ageno Walter,Guasti Luigina,Squizzato Alessandro in (2013)
Expert Opinion on Drug Metabolism and Toxicology,volume 9,issue 7 , Vol. 9, Iss. 7, 2013-07 , pp.